We’re focused on creating medicines that target the source of immune-mediated diseases.??? ? Learn more about our lead asset, solrikitug, a Phase 2 highly potent monoclonal antibody with the potential to be a life-changing medication for diseases where there is a need for improved treatment options: https://bit.ly/3MNVCSw ? #innovation #clinicaltrials #biopharma?
关于我们
At Uniquity Bio, we bring decades of experience from the world’s top pharmaceutical companies and research institutions into the rigorous — yet nimble — development of exciting, high-potential medicines.
- 网站
-
https://www.uniquity.com/
Uniquity Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股
Uniquity Bio员工
动态
-
As scientific advancements in the field of immunology and inflammation have rapidly expanded, so has the opportunity to deliver unprecedented benefits to people suffering from chronic and prevalent immune-mediated diseases. At Uniquity Bio, we are actively seeking to expand our immunology and inflammation pipeline, and are committed to the acquisition and parallel development of high-quality assets. ? Partner with us: https://bit.ly/3O5a3Cp ? #partner #immunology #inflammation #innovation
-
-
The interest (and investment) in I&I isn't slowing down - and neither are we. More from our CEO, Brian Lortie:
"The [investment] tide may be turning toward obesity and immunology and inflammation," BioSpace reports - and I couldn't agree more. This was certainly a theme at #JPM25, where our team was privileged to have many productive and strategic meetings discussing Uniquity Bio's rapidly-advancing program, solrikitug, and the new advancements we're seeing in this space, including the promise and value of bispecifics. Heather McKenzie's article is an interesting roundup of some of the recent innovations and macro trends that are driving investment dollars and developer attention:?bit.ly/4aracu6
-
Start off the year with a new role!? ?? At Uniquity Bio, we aim to develop high-potential medicines, and we’re looking for bright-minded professionals driven to advance science and make a difference for people living with I&I conditions. It's a great time to explore opportunities with us: https://bit.ly/42kAlZM ?? Director, Clinical Development Operations? ?? Executive Program Coordinator? ?? Clinical Research Scientist #Hiring #TeamUniquity #NewJob
-
-
With a focus on immunology and inflammation, we bring decades of experience from top pharmaceutical companies and research institutions to execute on our mission, our vision, and our purpose. We know what it takes to build strong companies and deliver important new medicines. Learn more about Uniquity:?https://bit.ly/3zj4vAm #biopharma #inflammation #mission?
-
2024 was a remarkable year for innovation and progress in biotech fueled by a number of large financing rounds – including our own! Thank you Kyle LaHucik for continuing to highlight this exciting milestone and the work we are doing to develop high-potential medicines in #immunology and #inflammation. https://lnkd.in/gaAkdxGb #innovation #biotech
-
#TeamUniquity made incredible strides in 2024! We are proud of our milestones and accomplishments this year and look forward to another productive year ahead.?? ? Take a look at some of our best moments. #culture #innovation?
-
At Uniquity, we’re proud to blend scientific rigor with nimble operations – enabling us to develop medicines with both precision and speed.?? ? Our Chief Scientific Officer, Dr. Hector Ortega, MD, ScD explains how this balance of science and agility creates better #patient outcomes.? ? Partner with us: https://bit.ly/3O5a3Cp ? #innovation #teamwork #biopharma #TeamUniquity
-
Eosinophilic esophagitis, or EoE, is an inflammatory disease of the esophagus that is growing in prevalence. ? ? Our Phase 2 #clinicaltrial in EoE is ongoing, as we pursue our goal of delivering a best-in-class treatment for people suffering from this disease.? ? To learn more or see if you qualify for the study, visit our website: https://bit.ly/3MNVCSw? ? #biopharma #immunology?
-
-
We’re #thankful for #TeamUniquity, whose dedication, compassion and tireless work to provide patients with novel #inflammation and #immunology therapies is at the center of everything we do. We wish everyone a #Thanksgiving full of joy and warmth this holiday season.